Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3). (Q37381231)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 1998

Language	Label	Description	Also known as
English	Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).	scientific article published on April 1998

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3). (English)

1 reference

Europe PubMed Central

20 August 2017

experimental autoimmune encephalomyelitis

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

Lovett-Racke AE

1

1 reference

Europe PubMed Central

20 August 2017

Bittner P

2

1 reference

Europe PubMed Central

20 August 2017

Cross AH

3

1 reference

Europe PubMed Central

20 August 2017

Carlino JA

4

1 reference

Europe PubMed Central

20 August 2017

Racke MK

5

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

20 August 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

20 August 2017

101

1 reference

Europe PubMed Central

20 August 2017

8

1 reference

Europe PubMed Central

20 August 2017

1797-1804

1 reference

Europe PubMed Central

20 August 2017

Insulin-like growth factor-1 stimulation of lymphopoiesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Insulin-like growth factor-I: potential for treatment of motor neuronal disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Immunological aspects of demyelinating diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

6 September 2017

Further characterisation of an IGF-I enhancing antibody: actions on IGF-I-induced hypoglycaemia and interaction with the analogue LR3IGF-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

28 September 2017

Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

28 September 2017

Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

26 June 2018

Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

2 September 2018

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

2 September 2018

Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

2 September 2018

Insulin-like growth factors cross the blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508763

2 September 2018

Effect of insulin, proinsulin and pancreatic extract on myelination and remyelination in organotypic nerve tissue in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The insulin-like growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during development and resolution of experimental allergic encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and bioavailability of rhIGF-I/IGFBP-3 in the rat and monkey

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actions of an IGF-I-enhancing antibody on IGF-I pharmacokinetics and tissue distribution: increased IGF-I bioavailability

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9541512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI1486

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37381231&oldid=2110032899"